This test detects mutations in key genes associated with endometrial cancer subtypes. It aids in classifying the tumor into distinct molecular subgroups, which is essential for tailoring treatment strategies and assessing prognosis.
Patients diagnosed with endometrial cancer who need a molecular profile to determine treatment or assess hereditary risk.
